The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,590,793 in first-year total cost, median $852,847.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-T (29)]2
- Special Emphasis Panel[ZNS1 SRB-T (23)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF FLORIDA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | BIOMARKER DISCOVERY AND VALIDATION IN PSP1U01NS102035-01A1 | DAWSON, TED M.PANDEY, AKHILESH | JOHNS HOPKINS UNIVERSITY, MD | $928,403 | ZNS1 |
| 2018 | Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts1U01NS107009-01 | DORSEY, EARL RAYMANGRAVITE, LARA MSCHWARZSCHILD, MICHAEL ASIMUNI, TANYA | MASSACHUSETTS GENERAL HOSPITAL, MA | $852,847 | ZNS1 |
| 2017 | Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression1U01NS102038-01 | CORCOS, DANIEL M.VAILLANCOURT, DAVID E | UNIVERSITY OF FLORIDA, FL | $809,543 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.